Comparison of WHO Mark III and HRP II ELISA for in vitro sensitivity of Plasmodium falciparum

Comparison of WHO Mark III and HRP II ELISA for in vitro sensitivity of Plasmodium falciparum

Background & objectives: Antimalarial drug resistance is a serious challenge to malaria control worldwide. In vitro sensitivity assays provide an early indication of emerging drug resistance. In vitro susceptibility of field and culture adapted Plasmodium falciparum isolates to different antimal...

Full description

Bibliographic Details
Main Authors: Supriya Sharma, Neelima Mishra, Neena Valecha, Anupkumar R Anvikar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Journal of Vector Borne Diseases
Subjects:
Drug sensitivity; HRP II ELISA assay; in vitro; malaria; Plasmodium falciparum; WHO Mark III assay
Online Access:http://www.jvbd.org/article.asp?issn=0972-9062;year=2016;volume=53;issue=4;spage=341;epage=347;aulast=Sharma;type=0

Internet

http://www.jvbd.org/article.asp?issn=0972-9062;year=2016;volume=53;issue=4;spage=341;epage=347;aulast=Sharma;type=0

Similar Items